Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | THAP5 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of THAP5 mRNA | CTD | PMID:22079256 | THAP5 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of THAP5 mRNA | CTD | PMID:27153756 | THAP5 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of THAP5 gene | CTD | PMID:27153756 | THAP5 | Human | aflatoxin M1 | decreases expression | EXP | | 6480464 | Aflatoxin M1 results in decreased expression of THAP5 mRNA | CTD | PMID:30928695 | THAP5 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of THAP5 mRNA | CTD | PMID:24449571 | THAP5 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of THAP5 mRNA | CTD | PMID:33212167 | THAP5 | Human | arsenite(3-) | decreases methylation | EXP | | 6480464 | arsenite results in decreased methylation of THAP5 promoter | CTD | PMID:23974009 | THAP5 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of THAP5 mRNA | CTD | PMID:35301059 | THAP5 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of THAP5 mRNA | CTD | PMID:35301059 | THAP5 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of THAP5 protein | CTD | PMID:21110952 | THAP5 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of THAP5 mRNA | CTD | PMID:27989131 | THAP5 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of THAP5 mRNA | CTD | PMID:37042841 | THAP5 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of THAP5 mRNA | CTD | PMID:29803840 | THAP5 | Human | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of THAP5 mRNA | CTD | PMID:21867686 | THAP5 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of THAP5 mRNA | CTD | PMID:23649840 | THAP5 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of THAP5 mRNA | CTD | PMID:22079256 | THAP5 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of THAP5 mRNA | CTD | PMID:22079256 | THAP5 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of THAP5 gene | CTD | PMID:29154799 | THAP5 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of THAP5 mRNA | CTD | PMID:29154799 | |